focus -WSS

focus

author：hotspot 2025-09-06 02:06:31 - browse：31433

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

knowledge

WSS

Medicare Advantage insurers face 0.2% cut to 2025 payments

Biogen walks away from Aduhelm, years after polarizing approval

A new initiative will help leaders fight the next pandemic

Why Medicare shouldn’t cover every FDA

Zyn nicotine pouches become unlikely player in latest culture war

How generative AI ratchets up security threats for health systems

hotspot

focus

focus

Dobbs anniversary: the lost opportunity of abortion as health care

A new initiative will help leaders fight the next pandemic

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

ChatGPT in medicine: STAT answers readers' burning questions

Pancreatic cancer early detection could be helped by AI

In Memoriam: Notable people who died in 2023

10 reasons why health care startups fail

Malaria cases in Florida and Texas: Here’s what you need to know

Anthony Fauci pushes back on GOP claims during Covid hearing

hotspot

STAT wants to know your pick for a great summer read or listen

Finland to offer bird flu vaccine to select groups of people, a possible global first

Humana’s losses in Medicare Advantage tank its stock

Vertex non

'Little Tech' descents on D.C., wanting a say in how AI is regulated

New clues to why women have higher risk of autoimmune disorders

knowledge

focus

leisure time

hotspot